Ever Supreme Bio Technology Co., Ltd (TPEX:6712)

TPEX:6712 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	353.19	301.68	336.44	353.57	641.1	68.88
Short-Term Investments	460.5	636.5	998.6	915.99	702.6	346.1
Cash & Short-Term Investments	813.69	938.18	1,335	1,270	1,344	414.98
Cash Growth	-42.82%	-29.73%	5.16%	-5.52%	223.80%	-30.15%
Accounts Receivable	102.96	193.99	100.63	84.94	33.66	15.4
Other Receivables	12.79	7.56	0.46	0.88	29.6	2.24
Receivables	115.75	201.54	101.09	85.82	63.27	17.63
Inventory	82.91	80.04	69.09	88.3	56.77	35.49
Prepaid Expenses	9.3	3.44	7.92	6.29	2.11	10.46
Other Current Assets	0.04	0.06	7.73	5.46	0.92	0.07
Total Current Assets	1,022	1,223	1,521	1,455	1,467	478.63
Property, Plant & Equipment	89.55	48.58	64.81	89.84	125.01	171.24
Long-Term Investments	854.58	796.16	471.31	376.37	333.27	112.51
Other Intangible Assets	9.87	10.15	10.65	11.95	11.14	9.9
Long-Term Deferred Tax Assets	10.46	10.73	1.71	30.32	78.2	80.56
Other Long-Term Assets	47.69	47.24	6.57	9.72	8.22	5.48
Total Assets	2,034	2,136	2,076	1,974	2,023	858.32
Accounts Payable	19.91	25.13	23.33	29.08	15	5.04
Accrued Expenses	-	2.4	1.96	3.98	10.49	3.62
Current Portion of Leases	10.62	1.71	5.4	4.5	11.87	9.87
Current Income Taxes Payable	82.67	68.07	46.76	10.47	21.04	-
Current Unearned Revenue	223.87	194.13	121.65	89.89	12.22	4.12
Other Current Liabilities	479.28	37.66	32.55	25.82	25.9	17.67
Total Current Liabilities	816.34	329.09	231.64	163.74	96.51	40.32
Long-Term Leases	36.17	1.14	0.5	13.36	22.55	33.34
Long-Term Deferred Tax Liabilities	10.31	10.82	-	3.59	3.82	0.05
Other Long-Term Liabilities	18.54	0.78	0.82	0.76	1.96	3.86
Total Liabilities	881.35	341.82	232.96	181.45	124.83	77.56
Common Stock	815.61	806.73	733.39	681.4	618.18	562.89
Additional Paid-In Capital	599.81	551.72	785.91	872.22	1,211	486.55
Retained Earnings	196.55	434.23	323.67	238.51	68.74	-300.86
Comprehensive Income & Other	-120.66	1.6	-	0.04	-	32.19
Shareholders' Equity	1,152	1,794	1,843	1,792	1,898	780.76
Total Liabilities & Equity	2,034	2,136	2,076	1,974	2,023	858.32
Total Debt	46.79	2.84	5.9	17.86	34.42	43.21
Net Cash (Debt)	766.9	935.33	1,329	1,252	1,309	371.77
Net Cash Growth	-45.75%	-29.63%	6.19%	-4.40%	252.17%	-33.40%
Net Cash Per Share	9.45	11.59	16.19	15.10	15.81	4.98
Filing Date Shares Outstanding	81.25	80.67	80.67	82.42	82.25	74.9
Total Common Shares Outstanding	81.25	80.67	80.67	82.42	82.25	74.9
Working Capital	205.34	894.16	1,289	1,292	1,370	438.31
Book Value Per Share	14.18	22.24	22.84	21.74	23.07	10.42
Tangible Book Value	1,143	1,784	1,832	1,780	1,887	770.86
Tangible Book Value Per Share	14.06	22.12	22.71	21.60	22.94	10.29
Machinery	-	93.5	91.2	85.39	82.64	104.52
Leasehold Improvements	-	63.28	65.23	65.23	63.9	63.64

Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.